Menu

NSF Calls for Harassment Prevention

The National Science Foundation reiterates its commitment “to eradicate gender-based discrimination in science” with a statement geared toward the institutions it funds.

Jan 27, 2016
Tracy Vence

ISTOCK PHOTO, © ZERNLIEWIn a statement issued this week (January 25), the National Science Foundation (NSF) told grantee institutions it would not tolerate harassment and that it will “will take all appropriate actions to ensure” that those receiving agency funding are compliant with federal antidiscrimination regulations.

“In light of recent, multiple reports of sexual harassment in science, NSF reiterates its unwavering dedication to inclusive workplaces,” the agency noted in its statement. “NSF does not tolerate sexual harassment and encourages members of the scientific community who experience such harassment to report such behavior immediately.”

As Inside Higher Ed noted, the NSF’s announcement followed on the heels of a January 15 letter from NASA Administrator Charles Bolden to grantee institutions. “I urge all of our NASA grantee institutions to examine closely their current policies and procedures for addressing allegations of misconduct such as harassment,” Bolden wrote. “Beyond the law, we must seek to create the kinds of welcoming and supportive program environments in which all students can flourish.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.